Introduction: Little is known about mechanical ventilation practices during patient transport outside of hospital in the civilian setting, although these practices may have clinical impact. Objective. We set out to describe ventilation practice, the use of lung-protective ventilation strategies, administration of sedation and neuromuscular blockade, and related critical events during out-of-hospital transport of ventilated patients.
Methods: We conducted a population-based retrospective cohort study. Ventilator, pharmacy, and clinical data were extracted from the database of the provincial transport medicine agency in Ontario, Canada. Patients at risk for acute lung injury were identified by explicit screening criteria and lung-protective ventilation was assessed according to evidence-based thresholds. Critical events occurring during transport consisting of clinical deterioration or resuscitative procedures were recorded. RESULTS. We identified 1,735 mechanically ventilated adults who received out-of-hospital transport. Volume control and pressure control were the most commonly used ventilation modes. The median tidal volume delivered during transport was 500 mL (interquartile range 450-600) with positive end-expiratory pressure (PEEP) of 5 cmH(2)O (5-7) and peak inspiratory pressure of 24 cmH(2)O (20-29). Most patients (92%) were ventilated with peak pressures < or = 35 cmH(2)O; 22% of patients were ventilated with PEEP < 5 cmH(2)O. Ventilation in patients at risk of acute lung injury was not significantly different, and 68% of this subgroup was ventilated within lung-protective thresholds. Sedation was administered in 1,235 transports (71.2%) with frequent repeat administration. Neuromuscular blockade was administered in 385 transports (22.2%). Critical events occurred during 297 (17.1%) transports, due primarily to new-onset hypotension (n = 208). New in-transit hypotension was independently associated with sedative administration.
Conclusions: In-transit mechanical ventilation practices are variable, although patient exposure to potentially injurious pressures and volumes is uncommon. The application of PEEP is modest. In-transit hypotension is common and associated with sedative administration. The extent to which these practices impact patient outcome is unclear.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/10903120902935264 | DOI Listing |
Pediatr Cardiol
January 2025
The Heart Center, Nationwide Children's Hospital, Columbus, OH, USA.
The C3PO collaborative, with a history of successful quality improvement (QI) initiatives, leveraged registry participants to develop a multi-center QI initiative to reduce adverse events (AEs) in congenital cardiac catheterization. A 32-person, interdisciplinary working group analyzed audited data for all congenital cardiac catheterization cases from 2014-2017. The primary outcome was the occurrence of any high-severity (level 3/4/5) AE.
View Article and Find Full Text PDFConserv Biol
January 2025
Chair of Wildlife Ecology and Management, Albert Ludwigs University of Freiburg, Freiburg, Germany.
Survival and cause-specific mortality rates are vital for evidence-based population forecasting and conservation, particularly for large carnivores, whose populations are often vulnerable to human-caused mortalities. It is therefore important to know the relationship between anthropogenic and natural mortality causes to evaluate whether they are additive or compensatory. Further, the relation between survival and environmental covariates could reveal whether specific landscape characteristics influence demographic performance.
View Article and Find Full Text PDFmBio
January 2025
Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
is a bacterium associated with colorectal cancer (CRC) tumorigenesis, progression, and metastasis. Fap2 is a fusobacteria-specific outer membrane galactose-binding lectin that mediates adherence to and invasion of CRC tumors. Advances in omics analyses provide an opportunity to profile and identify microbial genomic features that correlate with the cancer-associated bacterial virulence factor Fap2.
View Article and Find Full Text PDFCochrane Database Syst Rev
January 2025
Cochrane Kidney and Transplant, Centre for Kidney Research, The Children's Hospital at Westmead, Westmead, Australia.
Background: Cytomegalovirus (CMV) is a significant cause of morbidity and death in solid organ transplant recipients. Pre-emptive treatment of patients with CMV viraemia using antiviral agents has been suggested as an alternative to routine prophylaxis to prevent CMV disease. This is an update of a Cochrane review first published in 2006 and updated in 2013.
View Article and Find Full Text PDFHeliyon
January 2025
Biotechnology Unit, ICAR-Central Research Institute for Jute and Allied Fibres, Barrackpore, Kolkata, West Bengal, 700121, India.
Recent advances in genome editing tools and CRISPR-Cas technologies have enabled plant genome engineering reach new heights. The current regulatory exemptions for certain categories of genome edited products, such as those derived from SDN-1 and SDN-2, which are free of any transgene, have significantly accelerated genome editing research in a number of agricultural crop plants in different countries. Although CRISPR-Cas technology is becoming increasingly popular, it is still important to carefully consider a number of factors before planning and carrying conducting CRISPR-Cas studies.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!